Essen, Germany

Anja Buchmüller

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 11.8

ph-index = 5

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
29 patents (USPTO):

Title: Anja Buchmüller: A Pioneer in Vascular Disorder Innovations

Introduction: Anja Buchmüller, based in Essen, Germany, is a highly regarded inventor with an impressive portfolio of 29 patents. Her contributions to the field of medicinal chemistry, particularly in the treatment of vascular disorders, have garnered significant attention within the scientific community.

Latest Patents: Two of Anja Buchmüller’s latest inventions demonstrate her commitment to advancing medical science. The first, titled "Substituted S-alaninate derivatives," focuses on innovative ways to prepare these derivatives for use in medications aimed at treating and preventing vascular disorders, particularly thrombotic and thromboembolic complications. The second patent involves "Antibodies capable of binding to the coagulation factor XIa and uses thereof." This invention relates to antibodies designed to inhibit platelet aggregation, thereby reducing thrombus formation and offering potential new treatments for related diseases.

Career Highlights: Anja Buchmüller has made significant strides in her career by working at Bayer Pharma and Bayer Intellectual Property GmbH. These positions have allowed her to collaborate on various groundbreaking projects in the pharmaceutical industry, enhancing her knowledge and expertise in developing innovative therapeutics.

Collaborations: Throughout her career, Anja has worked alongside esteemed colleagues such as Christoph Gerdes and Susanne Röhrig. These collaborations have facilitated the sharing of ideas and expertise, further enriching the research and development of innovative medical solutions.

Conclusion: Anja Buchmüller stands out as a key figure in the realm of medical innovations, particularly in treatments for vascular disorders. Her extensive patent portfolio highlights her dedication to improving health outcomes through scientific innovation and collaborative efforts. As the field of medicinal chemistry continues to evolve, her contributions will undoubtedly play a crucial role in shaping future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…